N/A
Completed N=241
Peer-mentoring, Quality of Life and Caregiver Burden in Patients With Chronic Kidney Disease and Their Caregivers
Source: ClinicalTrials.gov NCT02429115 ↗Enrolled (actual)
241
Serious AEs
0.0%
Results posted
Dec 2019
Primary outcomePrimary: Slope of Change in Kidney Disease Quality of Life-36 Score — 2.21; 4.13; -0.50; 3.00 Scores on a scale / Months — p=<0.05
Summary
Receiving supportive mentoring from well-adjusted individuals who share similar experiences has had a positive influence on adjustment with some chronic diseases. In this study, patients with advanced chronic kidney disease and caregivers of such patients will be randomly assigned to one of three groups: (1) face-to-face PFPP-individuals will receive six months of PFPP peer-mentoring, along with an informational text; (2) online PFPP-individuals will receive six months of online peer-mentoring modeled after the PFPP program, along with an informational text; and (3) information-only control group-individuals will receive the text of the material provided to the other two groups. The study team's decision to include an online version is based on suggestions by previous participants who indicated that this would be convenient for individuals for whom distance and geographic location are major considerations of participation.
The investigators expect that both face-to-face and online peer-mentorship programs will result in improved quality of life among patients with advanced kidney disease and decreased feeling of burden among caregivers of these patients. The investigators also expect that mentorship will lead to improved engagement of patients in their own care.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Slope of Change in Kidney Disease Quality of Life-36 Score |
2.21; 4.13; -0.50; 3.00; 5.44; -0.99 | <0.05 sig |
| PRIMARY Slope of Change in Zarit Caregiver Burden Interview (ZBI) Score |
-2.49; -3.44; -1.26 | <0.05 sig |
| SECONDARY Slope of Change in Patient Activation Measure (PAM) |
0.95; 5.66; 0.02 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
- Diagnosed with stage 4 or 5 CKD by a physician / or caregiver to a patient with stage 4 or 5 CKD;
- at least 18 years of age;
- able to read and write in English at the 8th grade level;
- access to computer with internet and email capability
Exclusion Criteria
- inability to provide consent;
- younger than 18 years of age;
- prisoners
Data sourced from ClinicalTrials.gov (NCT02429115). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.